Tandem Diabetes Care | Stammkapital



Ordinary Share Capital Veränderung Datum
Abbott USD 25.12B 28M 2025-03
Align Technology USD 72.48M 572K 2025-06
AtriCure USD 49.69M 49.64M 2025-06
Baxter International USD 683M 0 2024-12
Becton, Dickinson and Co. USD 370.59M 406K 2025-06
Boston Scientific USD 17M 0 2025-03
Cooper Companies USD 21.8M 100K 2025-04
Dexcom USD 392.2M 391.8M 2025-06
Edwards Lifesciences USD 654.8M 500K 2024-12
Eli Lilly USD 946.83M 354.23M 2025-06
Globus Medical USD 135.05M 134.92M 2025-06
ICU Medical USD 24.68M 22.22M 2025-06
Insulet USD 70.39M 70.29M 2025-06
Integra LifeSciences USD 77.92M 77M 2025-06
Intuitive Surgical USD 358.42M 358.02M 2025-06
J&J USD 3.12B 0 2025-03
Masimo USD 54.3M 54.2M 2025-06
Medtronic USD 128K 128K 2025-04
Merit Medical Systems USD 59.22M 658.89M 2025-06
Roche Holding CHF 107M 0 2024-06
Stryker USD 382.3M 344.3M 2025-06
Tandem Diabetes Care USD 67.53M 67.46M 2025-06
Teleflex USD 44.19M 4M 2025-06
Zimmer Biomet Holdings USD 197.9M 194.7M 2025-06


Tandem Diabetes Care Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.